Oral Administration of Ethyl Acetate-Soluble Portion of Terminalia chebula Conferring Protection from Streptozotocin-Induced Diabetic Mellitus and Its Complications
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji-hoon | - |
dc.contributor.author | Hong, Chung-Oui | - |
dc.contributor.author | Koo, Yun-chang | - |
dc.contributor.author | Kim, Su-Jung | - |
dc.contributor.author | Lee, Kwang-Won | - |
dc.date.accessioned | 2021-09-07T06:38:16Z | - |
dc.date.available | 2021-09-07T06:38:16Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-11 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111244 | - |
dc.description.abstract | Terminalia chebula has been widely used in India as a folk medicine. This study investigated the in vivo anti-hyperglycemia and anti-diabetic complication effects of the EtOAc-soluble portion of ethanolic extract of T. chebula fruit (EETC) containing 29.4% chebulic acid. Rats were divided into non-diabetic, untreated diabetic and diabetic groups. Streptozotocin (40 mg/kg body weight (BW))-induced diabetic rats were orally administered the aminoguanidine (100 mg/kg BW), high dose (500 mg/kg BW; HEETC) and low dose (100 mg/kg BW; LEETC) for 13 weeks. HEETC administration reduced the levels of blood glucose and serum lipids, decreased malondialdehyde concentrations of serum and thoracic aorta in diabetic rats, and significantly improved serum biochemical values and the pathomorphological changes of the liver and kidney in diabetic rats. Also, HEETC decreased the advanced glycation end products (AGEs) distribution in testis seminiferous tubules. Therefore, HEETC has a merit to be a potent candidate to control glycemic and diabetic complications. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | GLYCATION END-PRODUCTS | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | REPRODUCTIVE-TRACT | - |
dc.subject | ANTIOXIDANT | - |
dc.subject | AMINOGUANIDINE | - |
dc.subject | PREVENTS | - |
dc.subject | INSULIN | - |
dc.subject | RETZ. | - |
dc.subject | RATS | - |
dc.subject | HYPERGLYCEMIA | - |
dc.title | Oral Administration of Ethyl Acetate-Soluble Portion of Terminalia chebula Conferring Protection from Streptozotocin-Induced Diabetic Mellitus and Its Complications | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwang-Won | - |
dc.identifier.scopusid | 2-s2.0-81455128723 | - |
dc.identifier.wosid | 000296270900009 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.34, no.11, pp.1702 - 1709 | - |
dc.relation.isPartOf | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 34 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1702 | - |
dc.citation.endPage | 1709 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | GLYCATION END-PRODUCTS | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | REPRODUCTIVE-TRACT | - |
dc.subject.keywordPlus | ANTIOXIDANT | - |
dc.subject.keywordPlus | AMINOGUANIDINE | - |
dc.subject.keywordPlus | PREVENTS | - |
dc.subject.keywordPlus | INSULIN | - |
dc.subject.keywordPlus | RETZ. | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | HYPERGLYCEMIA | - |
dc.subject.keywordAuthor | Terminalia chebula | - |
dc.subject.keywordAuthor | streptozotocin | - |
dc.subject.keywordAuthor | lipid peroxidation | - |
dc.subject.keywordAuthor | glutathione | - |
dc.subject.keywordAuthor | testicular dysfunction | - |
dc.subject.keywordAuthor | advanced glycation end product | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.